US Removes Black Box Warnings on Estrogen Patches
The US health department approved the removal of strict black box warnings from three estradiol transdermal patches to help ease menopausal hormone treatment shortages. Market output has doubled over the past year as manufacturers continue expanding production capacity.
The United States health department approved the removal of strict black box warnings from three estradiol transdermal patches on Friday afternoon. The hormone therapies treat menopause symptoms such as hot flashes and mood swings. Women across the country have faced difficulties securing these treatments amid surging demand.
